Publications

Skip to content

Press

New and Noteworthy

Flatiron Health announces research to be presented at  IASLC 2025 World Conference on Lung Cancer hosted by the International Association for the Study of Lung Cancer

Research
Real-world evidence
Precision medicine
Press releases
Small cell lung cancer
Non-small cell lung cancer

Flatiron Health appoints Nathan Hubbard as Chief Executive Officer
Flatiron Health triples global oncology research network, unlocking multinational evidence generation
Flatiron Health research on AI-driven cancer progression extraction presented at AACR Special Conference in Cancer Research: Artificial Intelligence and Machine Learning 2025

All the latest

Topics

Showing 9 of 0 results

Flatiron Health announces research to be presented at  IASLC 2025 World Conference on Lung Cancer hosted by the International Association for the Study of Lung Cancer
Flatiron Health appoints Nathan Hubbard as Chief Executive Officer
Flatiron Health triples global oncology research network, unlocking multinational evidence generation
Flatiron Health research on AI-driven cancer progression extraction presented at AACR Special Conference in Cancer Research: Artificial Intelligence and Machine Learning 2025
Adaptive Biotechnologies and Flatiron Health announce integration of clonoSEQ® MRD Testing into OncoEMR®
- Point of care
- Press releases
Newcastle Hospitals agree new data partnerships to improve care and treatment
- Press releases
Flatiron Health announces research to be presented at ASCO 2025
Flatiron Health announces research to be presented at ISPOR 2025
Flatiron Health joins Veeva’s Product Partner Program to accelerate oncology clinical research

Reimagining the infrastructure of cancer care

Resources
Publications
Company
Media
Careers
Contact Us

Clinical Research
Real-World Evidence
Point of Care

Legal, Privacy, and Compliance
Data Confidentiality Commitments
Cookie Settings
© FLATIRON HEALTH® 2025